![](https://trevarx.com/wp-content/uploads/2022/07/Trevarx-scan-768x512.jpg)
Welcome to the next generation of cancer imaging and treatment.
![](https://trevarx.com/wp-content/uploads/2022/06/molecule-85x85.png)
Powerful Small Molecule Platform
![](https://trevarx.com/wp-content/uploads/2022/06/diagnostic-85x85.png)
Predictive Companion Diagnostic
![](https://trevarx.com/wp-content/uploads/2022/06/therapy-85x85.png)
Targeted Alpha Therapy
Who We Are
We’re on a mission to cure breast, ovarian and prostate cancer. Our team of experts and scientific board of advisors have extensive experience in small molecule radiopharmaceuticals and a proven track record in scientific research and multi-center trials. We are well positioned to hit the ground running with our unique theranostic solution. Trevarx offers multi-center trial expertise, regulatory support and GMP manufacturing to foster rapid commercialization of our radiopharmaceutical technologies.
![](https://trevarx.com/wp-content/uploads/2022/12/Who-We-Are-trevarx-blue-1024x683.jpg)
![](https://trevarx.com/wp-content/uploads/2022/06/Trevarx-Logo-Image.png)
Why Trevarx?
Our unique approach takes advantage of the proven PARPi platform to identify PARP-1 expressing tumors to guide PARPi therapy and to deliver powerful cancer treatment via small molecule radioisotopes. This allows for more precise identification, targeting and destruction of cancer at the sub-cellular level through lethal, double-stranded DNA breaks.
Partner With Us
Learn how you can be a part of the paradigm-changing solution that will change the way we treat cancer.
Partner With Us
Learn how you can be a part of the paradigm-changing solution that will change the way we treat cancer.